Alzheimer's News Today | Phase 3 Trial for Agitation in Alzheimer's, Dementia Patients Initiated by Intra-Cellular Therapies Alzheimer's News Today New York City-based Intra-Cellular Therapies has started its ITI-007-201 Phase 3 clinical trial for the treatment of agitation in patients with dementia, including Alzheimer's disease, following the company's communication with the U.S. FDA. Intra ... |